Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
18.03.24
/
50%
€0.30
Target price
18.03.25
€55.09
Performance (%)
18.92%
Price
30.05.24
€0.35
Summary
This prediction is currently active. The BUY prediction by BTIG_Research currently has a performance of 18.92%. This prediction currently runs until 18.03.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | -0.565% | -0.565% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $60.00 price target on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
6.02%
30.05.24
30.05.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.36
08.05.24
08.05.24
€58.61
08.05.25
08.05.25
-2.76%
30.05.24
30.05.24